NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

Biotechnology

Health Care

Pharmaceutical

NovImmune

NovImmune's headquarters in Plan-les-ouates, Switzerland

Jack Barbut

Nathalie Muller

Oliver Eckelmann, Ph.D.

The Research and Development team at NovImmune is dedicated to advancing the discovery and development of therapeutic monoclonal antibodies for immune-related disorders. This team conducts cutting-edge research, develops innovative assays, and ensures the production and safety of antibodies through their expertise in various specialized fields such as protein engineering, bioprocess development, and non-clinical safety.

Research and Development

The Department Heads at NovImmune comprise experts leading critical areas including Cell Culture Development, Protein Engineering, Downstream Processing (DSP), Bioprocessing, and Exploratory Science & Translational Medicine. They collaborate to innovate and optimize the development and production of therapeutic monoclonal antibodies to treat immune-related disorders, ensuring cutting-edge research, efficiency, and clinical relevance in NovImmune's offerings.

Department Heads

The Project Management team at NovImmune is responsible for coordinating and overseeing the development of therapeutic monoclonal antibodies. This includes organizing project timelines, managing preclinical studies, ensuring compliance in Chemistry, Manufacturing, and Controls (CMC), and supporting all phases of project execution to ensure timely and effective development efforts.

NovImmune

Org chart

Teams

Research and Development

Department Heads

Project Management

Offices

NovImmune

Org chart

Teams

Research and Development

Department Heads

Project Management

Offices

Related companies